EPIDEMIOLOGY AND TRANSMISSION OF HIV-2 - WHY THERE IS NO HIV-2 PANDEMIC

被引:196
|
作者
DECOCK, KM
ADJORLOLO, G
EKPINI, E
SIBAILLY, T
KOUADIO, J
MARAN, M
BRATTEGAARD, K
VETTER, KM
DOORLY, R
GAYLE, HD
机构
[1] PROJET RETRO CI, ABIDJAN, COTE IVOIRE
[2] EMORY UNIV, SCH PUBL HLTH, ATLANTA, GA 30322 USA
[3] CTR DIS CONTROL & PREVENT, NATL CTR INFECT DIS, DIV HIV AIDS, ATLANTA, GA USA
来源
关键词
D O I
10.1001/jama.270.17.2083
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Although human immunodeficiency virus type 1 (HIV-1) and HIV-2 share modes of transmission, their epidemiologic characteristics differ and international spread of HIV-2 has been very limited. Recently, the prevalence of infection with HIV-1 but not HIV-2 has increased rapidly in different West African countries, where HIV-2 was probably present earlier. Among 19 701 women of reproductive age tested in Abidjan, Ivory Coast, between 1988 and 1992, the prevalence of HIV-1 infection increased from 5.0% to 9.2%, while that of HIV-2 declined from 2.6% to 1.5%. Differences in viral load may be responsible: reported results of virus culture and polymerase chain reaction assays suggest that at high CD4+ T-lymphocyte counts viral load is lower in HIV-2-infected than in HIV-1-infected persons; the efficacy of heterosexual and perinatal transmission of HIV-2 is less efficient than that of HIV-1 at this stage. At low (<0.20 x 10(9)/L [<200/muL]) CD4+ T-lymphocyte counts, virus isolation is equally successful for both viruses, and the efficacy of heterosexual transmission is similar. Differences in HIV-1 and HIV-2 natural history are reflected in differences in viral load, that for HIV-2 being lower until immunodeficiency is severe. Differences in viral load throughout most of the natural history of infection appear to correlate with lower transmissibility of HIV-2 than HIV-1, and are the likeliest explanation for their markedly different global epidemiology.
引用
收藏
页码:2083 / 2086
页数:4
相关论文
共 50 条
  • [21] HIV-2 IN UK
    TEDDER, RS
    OCONNOR, T
    LANCET, 1987, 1 (8537): : 869 - 869
  • [22] HIV-2 TRANSMISSION - IMPLICATIONS FOR SPREAD OF HIV-1
    OBRIEN, TR
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (12): : 903 - 904
  • [23] HIV-2 INFECTION
    STILLE, W
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1987, 112 (24) : 978 - 978
  • [24] MOLECULAR AND BIOLOGICAL CHARACTERISTICS OF A NOVEL HIV-2 ISOLATE, HIV-2(HOM)
    NICK, S
    DINIZ, CA
    BORN, G
    SAUTER, M
    PEES, HW
    MULLERLANTZSCH, N
    JAHN, G
    VIRUS RESEARCH, 1993, 29 (03) : 267 - 279
  • [25] Current HIV-2 Diagnostic Strategy Overestimates HIV-2 Prevalence in China
    Qiu, Maofeng
    Liu, Xin
    Jiang, Yan
    Nkengasong, John N.
    Xing, Wenge
    Pei, Lijian
    Parekh, Bharat S.
    JOURNAL OF MEDICAL VIROLOGY, 2009, 81 (05) : 790 - 797
  • [26] UPDATE ON THE EPIDEMIOLOGY OF HIV-2 IN WEST-AFRICA
    KANKI, P
    MBOUP, S
    MARLINK, R
    GUEYE, A
    ESSEX, M
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1991, 7 (02) : 233 - 233
  • [27] False negative anti-HIV-1 HIV-2 ELISAs in acute HIV-2 infection
    Christiansen, CB
    Jessen, TE
    Nielsen, C
    StaunOlsen, P
    VOX SANGUINIS, 1996, 70 (03) : 144 - 147
  • [28] 90-90-90 for HIV-2? Ending the HIV-2 epidemic by enhancing care and clinical management of patients infected with HIV-2
    Gottlieb, Geoffrey S.
    Raugi, Dana N.
    Smith, Robert A.
    LANCET HIV, 2018, 5 (07): : E390 - E399
  • [29] NUCLEOTIDE-SEQUENCE OF THE HIV-2 EHO GENOME, A DIVERGENT HIV-2 ISOLATE
    GALABRU, J
    REYCUILLE, MA
    HOVANESSIAN, AG
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1995, 11 (07) : 873 - 874
  • [30] EXON2 OF HIV-2 TAT CONTRIBUTES TO TRANSACTIVATION OF THE HIV-2 LTR BY INCREASING BINDING-AFFINITY TO HIV-2 TAR RNA
    RHIM, H
    RICE, AP
    NUCLEIC ACIDS RESEARCH, 1994, 22 (21) : 4405 - 4413